Akari Therapeutics, Plc (AKTX)
NASDAQ·Healthcare·Biotechnology
$8.25
-2.19%
Mkt Cap $4.49K
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$1,200.00
Range $1,200.00 – $1,200.00
Implied Upside
+14454.3%
Consensus $1,200.00 vs current $8.25